Trust Company of Vermont’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.7M Buy
+106,435
New +$12.5M 0.51% 47
2025
Q4
$11.2M Sell
106,545
-528
-0.5% -$49.6K 0.47% 54
2025
Q3
$8.99M Sell
107,073
-1,774
-2% -$146K 0.39% 61
2025
Q2
$8.62M Sell
108,847
-1,313
-1% -$104K 0.41% 66
2025
Q1
$9.89M Sell
110,160
-6,178
-5% -$577K 0.49% 60
2024
Q4
$11.6M Sell
116,338
-10,509
-8% -$1.08M 0.56% 51
2024
Q3
$14.4M Sell
126,847
-2,602
-2% -$309K 0.72% 42
2024
Q2
$16M Buy
129,449
+177
+0.1% +$22.8K 0.87% 31
2024
Q1
$17.1M Buy
129,272
+11,741
+10% +$1.45M 0.95% 27
2023
Q4
$12.8M Sell
117,531
-11,726
-9% -$1.22M 0.85% 33
2023
Q3
$13.3M Buy
129,257
+1,593
+1% +$172K 0.9% 29
2023
Q2
$14.7M Buy
127,664
+2,731
+2% +$310K 0.96% 26
2023
Q1
$13.3M Buy
124,933
+3,956
+3% +$427K 0.93% 28
2022
Q4
$13.4M Buy
120,977
+292
+0.2% +$29.8K 0.98% 28
2022
Q3
$10.4M Buy
120,685
+11,319
+10% +$1.01M 0.82% 32
2022
Q2
$9.97M Buy
109,366
+3,882
+4% +$344K 0.76% 37
2022
Q1
$8.65M Buy
105,484
+2,261
+2% +$178K 0.59% 52
2021
Q4
$7.91M Buy
103,223
+4,730
+5% +$377K 0.5% 63
2021
Q3
$7.4M Buy
98,493
+12,998
+15% +$989K 0.53% 63
2021
Q2
$6.65M Buy
85,495
+2,046
+2% +$152K 0.46% 65
2021
Q1
$6.14M Buy
83,449
+15,703
+23% +$1.16M 0.46% 68
2020
Q4
$5.29M Buy
67,746
+1,346
+2% +$103K 0.42% 71
2020
Q3
$5.26M Buy
66,400
+670
+1% +$52.5K 0.48% 64
2020
Q2
$4.85M Sell
65,730
-32,391
-33% -$2.44M 0.48% 67
2020
Q1
$7.2M Sell
98,121
-4,437
-4% -$349K 0.67% 49
2019
Q4
$8.9M Sell
102,558
-992
-1% -$81.5K 0.67% 53
2019
Q3
$8.32M Sell
103,550
-1,384
-1% -$111K 0.67% 51
2019
Q2
$8.4M Sell
104,934
-1,551
-1% -$119K 0.7% 52
2019
Q1
$8.45M Buy
106,485
+2,804
+3% +$210K 0.73% 51
2018
Q4
$7.56M Sell
103,681
-246
-0.2% -$17.4K 0.73% 53
2018
Q3
$7.04M Sell
103,927
-1,187
-1% -$75.6K 0.59% 57
2018
Q2
$6.09M Buy
105,114
+2,604
+3% +$147K 0.55% 59
2018
Q1
$5.33M Buy
102,510
+5,805
+6% +$314K 0.5% 62
2017
Q4
$5.19M Buy
96,705
+425
+0.4% +$23.6K 0.48% 64
2017
Q3
$5.88M Sell
96,280
-653
-0.7% -$39.6K 0.58% 57
2017
Q2
$5.93M Sell
96,933
-55
-0.1% -$3.35K 0.61% 56
2017
Q1
$5.88M Hold
96,988
0.64% 51
2016
Q4
$5.45M Buy
96,988
+7,086
+8% +$415K 0.63% 50
2016
Q3
$5.35M Buy
89,902
+2,566
+3% +$150K 0.67% 48
2016
Q2
$4.8M Buy
87,336
+1,262
+1% +$67.2K 0.64% 55
2016
Q1
$4.35M Sell
86,074
-475
-0.5% -$23.3K 0.61% 58
2015
Q4
$4.36M Buy
86,549
+1,473
+2% +$74.3K 0.63% 58
2015
Q3
$4.01M Sell
85,076
-245
-0.3% -$13K 0.62% 55
2015
Q2
$4.63M Buy
85,321
+1,880
+2% +$105K 0.67% 45
2015
Q1
$4.58M Buy
83,441
+1,038
+1% +$58.8K 0.67% 46
2014
Q4
$4.47M Sell
82,403
-834
-1% -$46.5K 0.65% 46
2014
Q3
$4.71M Buy
83,237
+1,134
+1% +$63.7K 0.71% 46
2014
Q2
$4.53M Buy
82,103
+230
+0.3% +$12.5K 0.7% 48
2014
Q1
$4.43M Buy
81,873
+541
+0.7% +$28K 0.73% 46
2013
Q4
$3.88M Sell
81,332
-823
-1% -$37.6K 0.65% 50
2013
Q3
$3.73M Sell
82,155
-1,386
-2% -$63.3K 0.68% 50
2013
Q2
$3.7M Buy
+83,541
New +$3.73M 0.72% 45

Other funds holding MRK

Trust Company of Vermont's MRK Position: Q2 2026 in Review

Trust Company of Vermont opened a new position in Merck (MRK) in Q2 2026: 106,435 shares worth $13.7M. The stake represents 0.51% of the portfolio and ranks #47 among its holdings. This is a return to the name: Trust Company of Vermont previously reported a position in MRK as recently as Q4 2025.

Trust Company of Vermont first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.1M in Q1 2024. 2,466 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Trust Company of Vermont held 106,435 shares of Merck worth $13.7M as of Q2 2026.
  • Merck was a new Trust Company of Vermont position in Q2 2026.
  • Merck made up 0.51% of Trust Company of Vermont's portfolio in Q2 2026, its #47 holding.
  • Trust Company of Vermont first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • Trust Company of Vermont's Merck position peaked at $17.1M in Q1 2024.
  • 2,466 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Trust Company of Vermont's 13F filing for Q2 2026, filed 7 Aug 2026.